1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Ivonescimab injection is rapidly shaping the landscape of inflammatory bowel disease (IBD) management, bringing targeted innovation, clinical integration, and real-world practice transformation to the forefront for healthcare leaders and stakeholders.
Market Snapshot: Ivonescimab Injection Market
The ivonescimab injection market is witnessing robust momentum as evolving immunology research and biosimilar competition drive change across clinical and healthcare delivery settings. Earlier adoption of biologic therapies, increased emphasis on real-world outcomes, and strategic collaborations are all contributing to a dynamic market environment. The introduction of sophisticated monoclonal antibody technology is enabling clinicians to target inflammatory pathways in Crohn’s disease and ulcerative colitis more precisely. Enhanced regulatory flexibility and adoption of digital health platforms are catalyzing integration, while pricing dynamics and supply chain resilience remain central to industry strategy.
Scope & Segmentation
This report delivers a comprehensive breakdown of the ivonescimab injection market across multiple dimensions:
- Indication: Crohn's disease (Induction, Maintenance) and ulcerative colitis (Induction, Maintenance).
- Route of Administration: Intravenous infusion and subcutaneous injection to support both controlled and decentralized care settings.
- Dosage Forms: Cartridge, pre-filled syringe, and vial options tailored for clinical, home, and specialty care requirements.
- Distribution Channels: Hospital, online, and retail pharmacies, providing broad market access and streamlining patient experience.
- End User Types: Clinics, including ambulatory clinics and physician offices; hospitals; and specialty centers, each driving adoption patterns and care models.
- Geographical Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (with key markets like United Kingdom, Germany, France, United Arab Emirates, South Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
- Key Companies: F. Hoffmann-La Roche Ltd., AbbVie Inc., Johnson & Johnson, Merck & Co., Inc., Amgen Inc., Bristol-Myers Squibb Company, Novartis AG, Sanofi S.A., Pfizer Inc., Eli Lilly and Company.
Key Takeaways for Senior Decision-Makers
- Ivonescimab injection’s technology enables selective targeting of inflammatory pathways, offering new options for patients not responsive to existing therapies.
- Therapy aligns with clinical requirements for both rapid symptom relief in induction and sustained mucosal healing in maintenance phases.
- Real-world data collection is increasingly guiding formulary decisions and payer strategies, emphasizing long-term outcomes and patient-reported benefits.
- Digital health integration and remote monitoring support timely adjustments, optimizing adherence and improving patient engagement at scale.
- Market dynamics reflect the need for strong differentiation, as head-to-head studies and pharmacoeconomic modeling drive procurement and rebate negotiations.
Tariff Impact and Supply Chain Realignments
Recent adjustments to United States tariff policies have introduced added complexity to ivonescimab injection supply chains. Import duties on pharmaceutical ingredients and injection devices are leading manufacturers to revisit sourcing and supply resilience. Dual-sourcing and investment in regional manufacturing are being employed to minimize supply risks, while commercial teams refine pricing strategies to reflect these upstream pressures. Active engagement with payers is enabling companies to maintain alignment with value-based contracts by focusing discussions on the therapy’s long-term clinical and economic value.
Methodology & Data Sources
This analysis applies a rigorous, multi-tiered approach, combining primary insights from in-depth interviews with healthcare experts, gastroenterologists, and supply chain leaders. Secondary research includes review of regulatory filings, clinical trial registries, and company disclosures. Data triangulation, comparative benchmarking, and advanced qualitative analysis techniques underpin the accuracy and reliability of the market assessment.
Why This Report Matters
- Empowers executives with actionable intelligence on product segmentation, adoption drivers, and evolving payer dynamics.
- Guides strategic planning for resilient supply chains and differentiated commercialization strategies in competitive and shifting regulatory environments.
- Supports evidence-based decisions for launch sequencing, resource allocation, and stakeholder engagement across distinct regional landscapes.
Conclusion
Ivonescimab injection is poised to redefine IBD care strategies for the coming years. Staying ahead requires informed decisions, agile supply networks, and ongoing collaboration among industry stakeholders to unlock sustainable growth.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Positive Phase III trial outcomes for Ivonescimab in triple-negative breast cancer patients driving market anticipation
5.2. Regulatory acceleration through orphan drug designation for Ivonescimab in rare hematologic disorders boosting developer interest
5.3. Strategic licensing partnership between key biopharmaceutical companies to expand Ivonescimab access in emerging Asian markets
5.4. Implementation of advanced continuous manufacturing technologies reducing production costs of Ivonescimab injection biologics
5.5. Inclusion of Ivonescimab in national reimbursement lists following health technology assessments in major EU markets
5.6. Reported real-world evidence of Ivonescimab safety and efficacy in combination with checkpoint inhibitors in melanoma
5.7. Competition analysis highlighting emergence of biosimilar monoclonal antibodies targeting the same antigen as Ivonescimab
5.8. Patient-centric access programs for Ivonescimab injection improving adherence in underserved rural communities
5.2. Regulatory acceleration through orphan drug designation for Ivonescimab in rare hematologic disorders boosting developer interest
5.3. Strategic licensing partnership between key biopharmaceutical companies to expand Ivonescimab access in emerging Asian markets
5.4. Implementation of advanced continuous manufacturing technologies reducing production costs of Ivonescimab injection biologics
5.5. Inclusion of Ivonescimab in national reimbursement lists following health technology assessments in major EU markets
5.6. Reported real-world evidence of Ivonescimab safety and efficacy in combination with checkpoint inhibitors in melanoma
5.7. Competition analysis highlighting emergence of biosimilar monoclonal antibodies targeting the same antigen as Ivonescimab
5.8. Patient-centric access programs for Ivonescimab injection improving adherence in underserved rural communities
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Ivonescimab Injection Market, by Indication
8.1. Introduction
8.2. Crohn's Disease
8.2.1. Induction
8.2.2. Maintenance
8.3. Ulcerative Colitis
8.3.1. Induction
8.3.2. Maintenance
8.2. Crohn's Disease
8.2.1. Induction
8.2.2. Maintenance
8.3. Ulcerative Colitis
8.3.1. Induction
8.3.2. Maintenance
9. Ivonescimab Injection Market, by Route
9.1. Introduction
9.2. Intravenous Infusion
9.3. Subcutaneous Injection
9.2. Intravenous Infusion
9.3. Subcutaneous Injection
10. Ivonescimab Injection Market, by Dosage Form
10.1. Introduction
10.2. Cartridge
10.3. Pre-Filled Syringe
10.4. Vial
10.2. Cartridge
10.3. Pre-Filled Syringe
10.4. Vial
11. Ivonescimab Injection Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Ivonescimab Injection Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Ambulatory Clinics
12.2.2. Physician Offices
12.3. Hospitals
12.4. Specialty Centers
12.2. Clinics
12.2.1. Ambulatory Clinics
12.2.2. Physician Offices
12.3. Hospitals
12.4. Specialty Centers
13. Americas Ivonescimab Injection Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Ivonescimab Injection Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Ivonescimab Injection Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. AbbVie Inc.
16.3.3. Johnson & Johnson
16.3.4. Merck & Co., Inc.
16.3.5. Amgen Inc.
16.3.6. Bristol-Myers Squibb Company
16.3.7. Novartis AG
16.3.8. Sanofi S.A.
16.3.9. Pfizer Inc.
16.3.10. Eli Lilly and Company
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.2. AbbVie Inc.
16.3.3. Johnson & Johnson
16.3.4. Merck & Co., Inc.
16.3.5. Amgen Inc.
16.3.6. Bristol-Myers Squibb Company
16.3.7. Novartis AG
16.3.8. Sanofi S.A.
16.3.9. Pfizer Inc.
16.3.10. Eli Lilly and Company
List of Figures
FIGURE 1. IVONESCIMAB INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IVONESCIMAB INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IVONESCIMAB INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. IVONESCIMAB INJECTION MARKET: RESEARCHAI
FIGURE 26. IVONESCIMAB INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 27. IVONESCIMAB INJECTION MARKET: RESEARCHCONTACTS
FIGURE 28. IVONESCIMAB INJECTION MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. IVONESCIMAB INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. IVONESCIMAB INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. IVONESCIMAB INJECTION MARKET: RESEARCHAI
FIGURE 26. IVONESCIMAB INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 27. IVONESCIMAB INJECTION MARKET: RESEARCHCONTACTS
FIGURE 28. IVONESCIMAB INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IVONESCIMAB INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CARTRIDGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 102. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 103. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 104. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 105. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 106. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 107. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 218. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 219. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 245. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 248. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 249. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 250. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 251. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 252. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 253. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 254. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 266. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 267. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 325. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 330. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 331. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 332. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 333. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 334. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 335. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INDUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY INTRAVENOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CARTRIDGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PRE-FILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY PHYSICIAN OFFICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL IVONESCIMAB INJECTION MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES IVONESCIMAB INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 102. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 103. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 104. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 105. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 106. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 107. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. CANADA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 124. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 202. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 203. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 213. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 218. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 219. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 222. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 245. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 248. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 249. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 250. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 251. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 252. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 253. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 254. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 260. ITALY IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 261. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 266. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 267. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA IVONESCIMAB INJECTION MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 325. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY CROHN'S DISEASE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2018-2024 (USD MILLION)
TABLE 330. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ULCERATIVE COLITIS, 2025-2030 (USD MILLION)
TABLE 331. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 332. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 333. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 334. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 335. DENMARK IVONESCIMAB INJECTION MARKET SIZE, BY DISTRIBUTION CHANNE
Samples
LOADING...
Companies Mentioned
The companies profiled in this Ivonescimab Injection Market report include:- F. Hoffmann-La Roche Ltd.
- AbbVie Inc.
- Johnson & Johnson
- Merck & Co., Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- Novartis AG
- Sanofi S.A.
- Pfizer Inc.
- Eli Lilly and Company
